Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; Acute inhalation toxicity; In vitro; In silico; Ex vivo; Quantitative structure-activity relationships (QSAR); Adverse outcome pathway; Aggregate exposure pathway; Dosimetry; Integrated approach to testing and assessment (IATA); Risk assessment; ADME; abs
مقالات ISI مدل فارماکوکینتیک مبتنی بر فیزیولوژی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; ADAM; advanced dissolution, absorption, and metabolism; AED; antiepileptic drug; AUC; area-under-the-curve; B/P; blood to plasma ratio; BID; twice daily; BMI; body mass index; CBZ; carbamazepine; CLint; intrinsic clearance; CLR; renal clearance; CL; clear
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; drug interaction; hepatic clearance; hepatic transport; organic anion-transporting polypeptide transporters; pharmacokinetics/pharmacodynamics; physiologically based pharmacokinetic model;
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; pediatric; Biopharmaceutics Classification System (BCS); in vitro models; physiologically based pharmacokinetic model; clinical trials;
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; D4; octamethylcyclotetrasiloxane; D5; decamethylcyclopentasiloxane; EI; electron impact; LOQ; limit of quantification; PBPK model; physiologically based pharmacokinetic model; PCPs; personal care products; TD-GD-MS; thermal desorption gas chromatography m
Virtual population pharmacokinetic using physiologically based pharmacokinetic model for evaluating bioequivalence of oral lacidipine formulations in dogs
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; Physiologically based pharmacokinetic model; Virtual population pharmacokinetic; Bioequivalence; Lacidipine; Amorphous solid dispersions;
Quantitative prediction of histamine H1 receptor occupancy by the sedative and non-sedative antagonists in the human central nervous system based on systemic exposure and preclinical data
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; Positron emission tomography; Central nervous system; Receptor occupancy; Histamine H1 receptor; P-glycoprotein; Physiologically based pharmacokinetic model; AUC; area under the curve; BBB; blood-brain barrier; CNS; central nervous system; Cblood; blood
Refinement of the oral exposure description in the cyclic siloxane PBPK model for rats and humans: Implications for exposure assessment
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; Cyclic volatile methyl siloxane; Oxtamethylcyclotetrasiloxane; Decamethylcyclopentasiloxane; D4; D5; Physiologically based pharmacokinetic model;
Determinants of Intestinal Availability for P-glycoprotein Substrate Drugs Estimated by Extensive Simulation With Mathematical Absorption Models
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; drug-drug interaction; P-glycoprotein; physiologically based pharmacokinetic model; modeling and simulation; intestinal absorption; substrate drug; CLh; hepatic clearance; CLr; renal clearance; CYP3A; cytochrome P450 3A; DDI; drug-drug interaction; EQ
Application of a physiologically based pharmacokinetic model for the evaluation of single-point plasma phenotyping method of CYP2D6
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; CYP2D6; Phenotyping method; Physiologically based pharmacokinetic model; Virtual population;
Prediction of CNS occupancy of dopamine D2 receptor based on systemic exposure and in vitro experiments
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; Positron emission tomography; Brain; Central nervous system; Human; Receptor occupancy; Dopamine D2 receptor; Physiologically based pharmacokinetic model; AUC; area under the blood concentration time curve; BBB; blood-brain barrier; BSA; bovine serum al
Development of an integrated multi-species and multi-dose route PBPK model for volatile methyl siloxanes - D4 and D5
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; Octamethylcyclotetrasiloxane; Decamethylcyclopentasiloxane; D4; D5; Siloxane; PBPK; Kinetics; Risk assessment; Cyclic volatile methyl siloxane; Pharmacokinetics; Physiologically based pharmacokinetic model;
Evaporation of decamethylcyclopentasiloxane (D5) from selected cosmetic products: Implications for consumer exposure modeling
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; BP; biphenyl; C&PCPs; cosmetics and personal care products; D5; decamethylcyclopentasiloxane; GC/FID; gas chromatography with flame ionization detector; HBSS; Hank's Balanced Salt Solution; HEPES; 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid; M4Q; t
Reconstructing exposures from biomarkers using exposure-pharmacokinetic modeling - A case study with carbaryl
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; Exposure reconstruction; Biomarker interpretation; Pharmacokinetic modeling; Physiologically based pharmacokinetic model; Carbaryl; Markov Chain Monte Carlo; Discretized Bayesian; Exposure conversion factor; CARES; Population-based biomonitoring;
Development and application of a rat PBPK model to elucidate kidney and liver effects induced by ETBE and tert-butanol
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; Gasoline oxygenates; Internal dosimetrics; Dose–response; Physiologically based pharmacokinetic model
Development of a physiologically based pharmacokinetic model for assessment of human exposure to bisphenol A
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; Bisphenol A; BPA; Physiologically based pharmacokinetic model; PBPK; Human
Human plasma concentrations of herbicidal carbamate molinate extrapolated from the pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and physiologically based pharmacokinetic modeling
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; Physiologically based pharmacokinetic model; Transplanted human liver cells; Lowest-observed-adverse-effect level; Simulation; Allometric scaling;
Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; Fenofibrate; Lipid-based formulation; Biorelevant dissolution tests; Permeability; Oral absorption; Physiologically based pharmacokinetic model;
Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; Absorption; Dissolution; Food effect; Permeability; Physiologically based pharmacokinetic model; Precipitation
Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; AUC; area under the curve; CL; lumen Cr concentration; Cr; chromium; Cr(III); trivalent chromium; Cr(VI); hexavalent chromium; GI; gastrointestinal; KM; Michaelis-Menten constant; L; small intestines section length; PBPK; physiologically based pharmacok
On the Accuracy of Estimation of Basic Pharmacokinetic Parameters by the Traditional Noncompartmental Equations and the Prediction of the Steady-State Volume of Distribution in Obese Patients Based Upon Data Derived from Normal Subjects
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; Steady-state volume of distribution; terminal volume of distribution; mean residence time; central elimination; physiologically based pharmacokinetic model; adipose tissue; tissue-plasma partition coefficient; obese subject; underweight subject;
The influence of hepatic transport on the distribution volumes and mean residence time of drug in the body and the accuracy of estimating these parameters by the traditional pharmacokinetic calculations
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; hepatic transport; steadyâstate volume of distribution; terminal volume of distribution; mean residence time; terminal halfâlife; hepatic clearance; central elimination; physiologically based pharmacokinetic model;
Evaluation and prediction of pharmacokinetics of PFOA and PFOS in the monkey and human using a PBPK model
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; PFAAs; collectively refers to perfluoroalkyl acid carboxylates and sulfonates; PBPK model; physiologically based pharmacokinetic model; PFOA; perfluorooctanoate; PFOS; perfluorooctane sulfonate; Physiologically-based pharmacokinetic modeling; PBPK; Toxico
A Valid Equation for the Well-Stirred Perfusion Limited Physiologically Based Pharmacokinetic Model that Consistently Accounts for the Blood-Tissue Drug Distribution in the Organ and the Corresponding Valid Equation for the Steady State Volume of Distribu
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; physiologically based pharmacokinetic model; perfusion limited model; well-stirred model; perfusion volume; tissue-plasma partition coefficient; blood-plasma concentration ratio; steady state volume of distribution; clearance;
A human physiological model describing acetone kinetics in blood and breath during various levels of physical exercise
Keywords: مدل فارماکوکینتیک مبتنی بر فیزیولوژی; Inert tube; Inhalation; Physiologically based pharmacokinetic model; Physiologically based toxicokinetic model; Polar solvent; Washin–washout effect